Kura Oncology, Inc.
KURA
$7.58
-$0.07-0.92%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 630.73M | 658.19M | 727.40M | 455.30M | 491.52M |
Total Receivables | 4.57M | 54.05M | 6.10M | 4.70M | 4.70M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 24.77M | 11.96M | 11.33M | 3.19M | 3.55M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 660.08M | 724.20M | 744.83M | 463.19M | 499.77M |
|
|||||
Total Current Assets | 660.08M | 724.20M | 744.83M | 463.19M | 499.77M |
Net Property, Plant & Equipment | 11.78M | 10.49M | 7.49M | 7.42M | 7.92M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 10.57M | 9.08M | 7.85M | 8.23M | 7.43M |
Total Assets | 682.43M | 743.76M | 760.16M | 478.84M | 515.12M |
|
|||||
Total Accounts Payable | 1.70M | 4.61M | 1.47M | 3.01M | 2.06M |
Total Accrued Expenses | 51.23M | 38.20M | 46.42M | 33.96M | 29.07M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.81M | 3.83M | 4.49M | 3.41M | 2.31M |
Total Finance Division Other Current Liabilities | 49.44M | 43.13M | 26.33M | -- | -- |
Total Other Current Liabilities | 49.44M | 43.13M | 26.33M | -- | -- |
Total Current Liabilities | 107.17M | 89.77M | 78.71M | 40.37M | 33.45M |
|
|||||
Total Current Liabilities | 107.17M | 89.77M | 78.71M | 40.37M | 33.45M |
Long-Term Debt | 6.51M | 7.65M | 6.92M | 7.76M | 8.58M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 8.16M | 7.88M | 5.19M | 5.47M | 5.84M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 255.10M | 274.06M | 255.70M | 1.47M | 1.18M |
Total Liabilities | 376.94M | 379.36M | 346.52M | 55.07M | 49.05M |
|
|||||
Common Stock & APIC | 1.32B | 1.32B | 1.31B | 1.30B | 1.29B |
Retained Earnings | -1.02B | -952.85M | -895.42M | -876.21M | -821.80M |
Treasury Stock & Other | 711.00K | 974.00K | 764.00K | 1.12M | -463.00K |
Total Common Equity | 305.49M | 364.41M | 413.64M | 423.77M | 466.07M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 305.49M | 364.41M | 413.64M | 423.77M | 466.07M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 305.49M | 364.41M | 413.64M | 423.77M | 466.07M |
|